Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions
Jürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a sign...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-07-01
|
Series: | Research and Reports in Urology |
Subjects: | |
Online Access: | https://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRU |
id |
doaj-997b94731ca84a7797abda8344dc4b02 |
---|---|
record_format |
Article |
spelling |
doaj-997b94731ca84a7797abda8344dc4b022020-11-24T21:29:59ZengDove Medical PressResearch and Reports in Urology2253-24472017-07-01Volume 912112733705Management of urinary tract infections in patients with neurogenic bladder: challenges and solutionsPannek JWöllner JJürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a significant morbidity and mortality, and they affect the quality of life of the affected patients. Diagnosis and treatment of UTI in this group of patients are challenging. In this review, the current strategies regarding diagnosis, treatment, and prevention are summarized. Diagnostics: it is important to correctly diagnose a UTI, as treatment of bacteriuria should strictly be avoided. A UTI is defined as a combination of laboratory findings (leukocyturia and bacteriuria) and symptoms. Laboratory findings without symptoms are classified as asymptomatic bacteriuria. Routine urine screening is not advised. Treatment: Only UTI should be treated; treatment of asymptomatic bacteriuria is not indicated. Prior to treatment, urine for a urine culture should be obtained. Antibiotic treatment for ~7 days is advised. Prevention: In recurrent UTI, bladder management should be optimized and morphologic causes for UTI should be excluded. If UTIs persist, medical prophylaxis should be considered. Currently, no prophylactic measure with evidence-based efficacy exists. Long-term antibiotic prophylaxis should be used merely as an ultimate measure. Among the various mentioned innovative approaches for UTI prevention, bacteriophages, intravesical instillations, complementary and alternative medicine techniques, and probiotics seem to be most promising. Conclusion: Recently, several promising innovative options for UTI prophylaxis have been developed which may help overcome the current therapeutic dilemma. However, further well designed studies are necessary to evaluate the safety and efficacy of these approaches. Keywords: neurogenic lower urinary tract dysfunction, spinal cord injury, prophylaxis, resistance, lactobacilli, cranberrieshttps://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRUneurogenic lower urinary tract dysfunctionurinary tract infectionprophylaxisspinal cord injury |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pannek J Wöllner J |
spellingShingle |
Pannek J Wöllner J Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions Research and Reports in Urology neurogenic lower urinary tract dysfunction urinary tract infection prophylaxis spinal cord injury |
author_facet |
Pannek J Wöllner J |
author_sort |
Pannek J |
title |
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
title_short |
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
title_full |
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
title_fullStr |
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
title_full_unstemmed |
Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
title_sort |
management of urinary tract infections in patients with neurogenic bladder: challenges and solutions |
publisher |
Dove Medical Press |
series |
Research and Reports in Urology |
issn |
2253-2447 |
publishDate |
2017-07-01 |
description |
Jürgen Pannek, Jens Wöllner Neuro-Urology, Swiss Paraplegic Center, Nottwil, Switzerland Introduction: Urinary tract infections (UTIs) are one of the most common morbidities in persons with neurogenic lower urinary tract dysfunction (NLUTD). They are associated with a significant morbidity and mortality, and they affect the quality of life of the affected patients. Diagnosis and treatment of UTI in this group of patients are challenging. In this review, the current strategies regarding diagnosis, treatment, and prevention are summarized. Diagnostics: it is important to correctly diagnose a UTI, as treatment of bacteriuria should strictly be avoided. A UTI is defined as a combination of laboratory findings (leukocyturia and bacteriuria) and symptoms. Laboratory findings without symptoms are classified as asymptomatic bacteriuria. Routine urine screening is not advised. Treatment: Only UTI should be treated; treatment of asymptomatic bacteriuria is not indicated. Prior to treatment, urine for a urine culture should be obtained. Antibiotic treatment for ~7 days is advised. Prevention: In recurrent UTI, bladder management should be optimized and morphologic causes for UTI should be excluded. If UTIs persist, medical prophylaxis should be considered. Currently, no prophylactic measure with evidence-based efficacy exists. Long-term antibiotic prophylaxis should be used merely as an ultimate measure. Among the various mentioned innovative approaches for UTI prevention, bacteriophages, intravesical instillations, complementary and alternative medicine techniques, and probiotics seem to be most promising. Conclusion: Recently, several promising innovative options for UTI prophylaxis have been developed which may help overcome the current therapeutic dilemma. However, further well designed studies are necessary to evaluate the safety and efficacy of these approaches. Keywords: neurogenic lower urinary tract dysfunction, spinal cord injury, prophylaxis, resistance, lactobacilli, cranberries |
topic |
neurogenic lower urinary tract dysfunction urinary tract infection prophylaxis spinal cord injury |
url |
https://www.dovepress.com/management-of-urinary-tract-infections-in-patients-with-neurogenic-bla-peer-reviewed-article-RRU |
work_keys_str_mv |
AT pannekj managementofurinarytractinfectionsinpatientswithneurogenicbladderchallengesandsolutions AT wollnerj managementofurinarytractinfectionsinpatientswithneurogenicbladderchallengesandsolutions |
_version_ |
1725964710759628800 |